Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
BSX.PRA was delisted on the 31st of May, 2023.
1 hedge funds and large institutions have $3.62M invested in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in 2021 Q2 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
45% less capital invested
Capital invested by funds: $6.63M → $3.62M (-$3M)
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LTI
Laffer Tengler Investments
Nashville,
Tennessee
|
+$597K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Rational Advisors
Huntington,
New York
|
-$3.8M |
BSX.PRA Hedge Fund Activity: Q2 2021 in Review
1 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) for Q2 2021, worth a combined $3.62M — down 45% from $6.63M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of BSX.PRA and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was Laffer Tengler Investments, adding an estimated $597K. The largest seller was Rational Advisors, exiting entirely with an estimated $3.8M sold.
- 1 institutional investor held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) as of Q2 2021, down from 2 in Q1 2021.
- Funds reported $3.62M of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A stock for Q2 2021, down 45% quarter-over-quarter.
- 0 funds opened new Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A positions in Q2 2021 and 1 closed out, a net change of -1 holder.
- The largest Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A buyer in Q2 2021 was Laffer Tengler Investments, an estimated $597K added.
- The largest Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A seller in Q2 2021 was Rational Advisors, an estimated $3.8M sold.
Based on aggregated 13F filings for Q2 2021.